Join
Live feed
·
PRReleasevia Quantisnow
GlucoTrack Inc. logo

Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology

ByQuantisnow·Wall Street's wire, on your screen.
GCTK· GlucoTrack Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GCTK (GlucoTrack Inc.) and more on Quantisnow.